J. Bichler

498 total citations
16 papers, 405 citations indexed

About

J. Bichler is a scholar working on Hematology, Surgery and Molecular Biology. According to data from OpenAlex, J. Bichler has authored 16 papers receiving a total of 405 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 6 papers in Surgery and 5 papers in Molecular Biology. Recurrent topics in J. Bichler's work include Blood Coagulation and Thrombosis Mechanisms (7 papers), Heparin-Induced Thrombocytopenia and Thrombosis (6 papers) and Hemophilia Treatment and Research (6 papers). J. Bichler is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (7 papers), Heparin-Induced Thrombocytopenia and Thrombosis (6 papers) and Hemophilia Treatment and Research (6 papers). J. Bichler collaborates with scholars based in Germany, United Kingdom and Austria. J. Bichler's co-authors include Hans Fritz, Matthias Siebeck, Sigurd Knaub, Toshko Lissitchkov, Andreas Tiede, Johannes Oldenburg, J. H. Chesebro, Whyte G. Owen, Pierre Zoldhelyi and L. Rusen and has published in prestigious journals such as Circulation, Biochemical Journal and Thrombosis Research.

In The Last Decade

J. Bichler

16 papers receiving 385 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. Bichler Germany	13	237	137	107	103	51	16	405
Elke Bucha Germany	12	122 0.5×	312 2.3×	187 1.7×	232 2.3×	45 0.9×	27	466
Jawed Fareed United States	10	76 0.3×	154 1.1×	209 2.0×	219 2.1×	48 0.9×	16	402
Rachel Petermann France	8	126 0.5×	60 0.4×	25 0.2×	17 0.2×	31 0.6×	25	258
Alexander E Kogan Russia	10	75 0.3×	62 0.5×	203 1.9×	29 0.3×	62 1.2×	24	354
Sandra Le Quellec France	10	247 1.0×	23 0.2×	77 0.7×	47 0.5×	61 1.2×	31	385
Birgit Jurlander Denmark	7	134 0.6×	78 0.6×	156 1.5×	14 0.1×	37 0.7×	14	349
Nikola Ivetic Canada	11	162 0.7×	82 0.6×	11 0.1×	26 0.3×	43 0.8×	21	298
Jana Žolková Slovakia	10	112 0.5×	32 0.2×	43 0.4×	36 0.3×	22 0.4×	26	268
Esther Pellham United States	12	218 0.9×	37 0.3×	11 0.1×	12 0.1×	28 0.5×	24	433
Jovana Yudin Canada	5	38 0.2×	52 0.4×	247 2.3×	176 1.7×	27 0.5×	6	353

Countries citing papers authored by J. Bichler

Since Specialization

Citations

This map shows the geographic impact of J. Bichler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Bichler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Bichler more than expected).

Fields of papers citing papers by J. Bichler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Bichler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Bichler. The network helps show where J. Bichler may publish in the future.

Co-authorship network of co-authors of J. Bichler

This figure shows the co-authorship network connecting the top 25 collaborators of J. Bichler. A scholar is included among the top collaborators of J. Bichler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Bichler. J. Bichler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Klukowska, Anna, et al.. (2018). Long‐term tolerability, immunogenicity and efficacy of Nuwiq^® (human‐cl rhFVIII) in children with severe haemophilia A. Haemophilia. 24(4). 595–603. 12 indexed citations

Dargaud, Yesim, Claude Négrier, L. Rusen, et al.. (2018). Individual thrombin generation and spontaneous bleeding rate during personalized prophylaxis with Nuwiq^®(human‐cl rhFVIII) in previously treated patients with severe haemophilia A. Haemophilia. 24(4). 619–627. 22 indexed citations

Lissitchkov, Toshko, L. Rusen, Pencho Georgiev, et al.. (2017). PK‐guided personalized prophylaxis with Nuwiq^® (human‐cl rhFVIII) in adults with severe haemophilia A. Haemophilia. 23(5). 697–704. 43 indexed citations

Kessler, Craig M., Anna Klukowska, Mario von Depka, et al.. (2017). Efficacy and safety of Nuwiq^® (human‐cl rhFVIII) in patients with severe haemophilia A undergoing surgical procedures. Haemophilia. 24(1). 70–76. 7 indexed citations

Lissitchkov, Toshko, K. K. Hampton, Mario von Depka, et al.. (2015). Novel, human cell line‐derived recombinant factor VIII (human‐cl rhFVIII; Nuwiq^®) in adults with severe haemophilia A: efficacy and safety. Haemophilia. 22(2). 225–231. 29 indexed citations

Tiede, Andreas, Johannes Oldenburg, Toshko Lissitchkov, et al.. (2015). Prophylaxis vs. on‐demand treatment with Nuwiq^® (Human‐cl rhFVIII) in adults with severe haemophilia A. Haemophilia. 22(3). 374–380. 28 indexed citations

Bichler, J., et al.. (2004). Pharmacokinetics and safety of recombinant anti‐RhD in healthy RhD‐negative male volunteers. Transfusion Medicine. 14(2). 165–171. 10 indexed citations

Close, Philippe, J. Bichler, Roger Kerry, et al.. (1994). Weak allergenicity of recombinant hirudin CGP 39393 (REVASC) in immunocompetent volunteers. The European Hirudin in Thrombosis Group (HIT Group).. PubMed. 5(11). 943–9. 33 indexed citations

Zoldhelyi, Pierre, J. Bichler, Whyte G. Owen, et al.. (1994). Persistent thrombin generation in humans during specific thrombin inhibition with hirudin.. Circulation. 90(6). 2671–2678. 45 indexed citations

10.

Bichler, J., John Baynes, & S R Thorpe. (1993). Catabolism of hirudin and thrombin-hirudin complexes in the rat. Biochemical Journal. 296(3). 771–776. 13 indexed citations

11.

Bichler, J., Matthias Siebeck, R. Maschler, H. Pelzer, & Hans Fritz. (1991). Determination of thrombin - hirudin complex in plasma with an enzyme-linked immunosorbent assay. Blood Coagulation & Fibrinolysis. 2(1). 129–134. 25 indexed citations

12.

Bichler, J., et al.. (1991). Studies for revealing a possible sensitization to hirudin after repeated intravenous injections in baboons. Thrombosis Research. 61(1). 39–51. 27 indexed citations

13.

Bichler, J. & Hans Fritz. (1991). Hirudin, a new therapeutic tool?. Annals of Hematology. 63(2). 67–76. 35 indexed citations

14.

Spannagl, M., et al.. (1991). Development of a chromogenic substrate assay for the determination of hirudin in plasma. Blood Coagulation & Fibrinolysis. 2(1). 121–128. 27 indexed citations

15.

Bichler, J., Matthias Siebeck, B. Fichtl, & Hans Fritz. (1991). Pharmacokinetics, Effect on Clotting Tests and Assessment of the Immunogenic Potential of Hirudin after a Single Subcutaneous or Intravenous Bolus Administration in Man. Pathophysiology of Haemostasis and Thrombosis. 21(Suppl. 1). 137–141. 9 indexed citations

16.

Bichler, J., et al.. (1988). Pharmacokinetics and pharmacodynamics of hirudin in man after single subcutaneous and intravenous bolus administration.. PubMed. 38(5). 704–10. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact